GlassScriptPhysician profile
Lisa A Garner
NPI 1982664280
$573.85
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $230 · 2020: $115 · 2021: $77.05 · 2022: $49.19 · 2023: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $101.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $120.77 | 2021-2023 | |
| Regeneron Healthcare Solutions, INC. | $115.43 | 2020 | |
| Galderma Laboratories, L.P. | $81.75 | 2019 | |
| Allergan, INC. | $47.71 | 2019 | |
| Janssen Scientific Affairs, LLC | $29.47 | 2021 | |
| Prugen, INC. Pharmaceuticals | $24.02 | 2019 | |
| Leo Pharma INC. | $21.71 | 2019 | |
| Pfizer INC. | $21.64 | 2023 | |
| Verrica Pharmaceuticals INC. | $20.69 | 2023 | Ycanth |
| Strata Skin Sciences, INC. | $19.57 | 2019 | |
| Genzyme Corporation | $19.39 | 2019 | |
| Incyte Corporation | $18.66 | 2021 | |
| Amgen INC. | $16.79 | 2023 | Otezla |
| Dusa Pharmaceuticals, INC. | $16.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Garner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.